Sartorius Stedim Biotech S.A. logo

Sartorius Stedim Biotech S.A.

SDMHF | OTC
Chart Builder DCF Calculator
$248.00
-$6.56 (-2.58%)
At close: Oct 30, 2026, 10:10 AM ET
$248.00
$0.00 (0.00%)
After-hours: Oct 30, 2026, 4:00 PM ET

Market Data

Market Cap
$24.13B
Enterprise Value
$23.44B
Beta
1.15
Average Volume
1.55K
Shares Outstanding (Diluted)
97.3M
Shares Change YoY
0%
Institutional Ownership
N/A
Exchange
OTC
ISIN
FR0013154002

Price Performance

Price Change 1M
1.6%
Price Change 3M
28.5%
Price Change 6M
37.0%
Price Change YTD
0.8%
Price Change 1Y
2.5%
Price Change 3Y
34.0%
Price Change 5Y
-55.2%
1M CAGR (ann.)
10.8%
1Y CAGR (ann.)
1.9%
5Y CAGR (ann.)
-14.3%
All-Time CAGR
13.2%

Valuation

PE Ratio
63.91
Forward PE
36.58
PEG Ratio
2.82
Forward PEG
5.08
PS Ratio
6.78
Forward PS
6.20
PB Ratio
4.86
P/FCF Ratio
77.06
P/Adj. FCF Ratio
77.06
P/OCF Ratio
33.56
EV/Sales
7.66
EV/EBIT
40.79
EV/EBITDA
26.02
EV/FCF
86.96
Earnings Yield
1.5%
FCF Yield
1.3%
Adj. FCF Yield
1.3%

Financial Health

Net Debt
€1.99B
Total Debt
€2.31B
Cash & Short-Term Investments
€172M
Total Assets
€8.04B
Current Ratio
1.22
Quick Ratio
0.57
Debt / Equity Ratio
0.53
Debt / EBITDA
2.57
Debt / FCF
8.57
OCF / Debt
0.27
Interest Coverage
3.78
Altman Z-Score
4.67
Piotroski F-Score
7

Margins & Profitability

Gross Profit Margin
44.5%
Operating Profit Margin
19.4%
EBITDA Margin
29.4%
Net Profit Margin
10.6%
FCF Margin
8.8%
Adj. FCF Margin
8.8%
SBC / Revenue
0.0%
SBC Impact (per share)
N/A

Returns

Return on Assets
4.0%
Return on Equity
7.7%
Return on Invested Capital
6.0%
Return on Capital Employed
8.6%
Return on Tangible Assets
8.8%

Historical Growth (CAGR)

Revenue CAGR 3Y
1.1%
Revenue CAGR 5Y
3.0%
Revenue CAGR 10Y
11.7%
EPS CAGR 3Y
-12.3%
EPS CAGR 5Y
-10.5%
EPS CAGR 10Y
7.8%
FCF CAGR 3Y
31.9%
FCF CAGR 5Y
-5.5%
FCF CAGR 10Y
13.6%

Analyst Forecasts

Analyst Rating
N/A
Analyst Count
N/A
EPS Growth Next 3Y
25.6%
Revenue Growth Next 3Y
11.8%
Earnings Date
Feb 23, 2027
EPS Estimate (next Q)
$1.84
EPS Growth Est (next Q)
24.2%
Revenue Est (next Q)
$1.06B
Revenue Growth Est (next Q)
4.5%

Fair Value Estimates

Graham Number
$65.97
Graham Upside
-73.4%
Lynch Fair Value
$19.40
Lynch Upside
-92.2%
Price Target
N/A
Price Target Upside
N/A

Cash Flow

Operating Cash Flow
€618.5M
Free Cash Flow
€269.5M
Adj. Free Cash Flow
€269.5M
FCF Per Share
$2.77
OCF Per Share
$6.36
OCF/S Ratio
20.2%

Income Statement

Revenue
€3.06B
Gross Profit
€1.36B
Operating Income
€592.8M
EBITDA
€900.7M
Net Income
€323.9M
EPS (Diluted)
$3.34
Revenue / Employee
$298.25K
Profit / Employee
$31.55K
Employees
10,265

Dividends

Annual Dividend
$0.80
Dividend Yield
0.32%
Payout Ratio
24.0%
FCF Payout Ratio
24.9%
Adj. FCF Payout Ratio
24.9%
Dividend Growth (YoY)
7.6%
Pay Frequency
Annual
Ex-Dividend Date
Apr 1, 2026

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.